Correlation Between CRISPR Therapeutics and Plus500

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Plus500 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Plus500 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and Plus500, you can compare the effects of market volatilities on CRISPR Therapeutics and Plus500 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Plus500. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Plus500.

Diversification Opportunities for CRISPR Therapeutics and Plus500

  Correlation Coefficient

Very weak diversification

The 3 months correlation between CRISPR and Plus500 is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Plus500 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Plus500 and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Plus500. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Plus500 has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Plus500 go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Plus500

Given the investment horizon of 90 days CRISPR Therapeutics AG is expected to under-perform the Plus500. In addition to that, CRISPR Therapeutics is 1.59 times more volatile than Plus500. It trades about -0.04 of its total potential returns per unit of risk. Plus500 is currently generating about 0.22 per unit of volatility. If you would invest  1,783  in Plus500 on May 18, 2022 and sell it today you would earn a total of  175.00  from holding Plus500 or generate 9.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
ValuesDaily Returns

CRISPR Therapeutics AG  vs.  Plus500

 Performance (%) 
CRISPR Therapeutics 
CRISPR Performance
10 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, CRISPR Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

CRISPR Price Channel

Plus500 Performance
9 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Plus500 are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Plus500 may actually be approaching a critical reversion point that can send shares even higher in September 2022.

Plus500 Price Channel

CRISPR Therapeutics and Plus500 Volatility Contrast

   Predicted Return Density   

Pair Trading with CRISPR Therapeutics and Plus500

The main advantage of trading using opposite CRISPR Therapeutics and Plus500 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Plus500 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Plus500 will offset losses from the drop in Plus500's long position.

CRISPR Therapeutics AG

Pair trading matchups for CRISPR Therapeutics

The idea behind CRISPR Therapeutics AG and Plus500 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.


Pair trading matchups for Plus500

Abeona Therapeutics vs. Plus500
Abbott Laboratories vs. Plus500
Microsoft Corp vs. Plus500
Costco Wholesale vs. Plus500
McDonalds Corp vs. Plus500
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Plus500 as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Plus500's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Plus500's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Plus500.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal